Jakub Rosik

2.0k citations
34 papers · 1.3k indexed · 1 hit paper · h-index 15
Topics
COVID-19 Clinical Research Studies (6 papers)SARS-CoV-2 and COVID-19 Research (5 papers)Rheumatoid Arthritis Research and Therapies (4 papers)
Journals
SHILAP Revista de lepidopterologíaInternational Journal of Molecular SciencesBiotechnology Advances

In The Last Decade

Jakub Rosik

33 papers receiving 1.3k citations

Hit Papers

An update on drugs with therapeutic potential for SARS-Co...2021202620222024202150100150

Peers

Jakub Rosik
Comparison fields: 5 of 127
  • Molecular Biology 445
  • Infectious Diseases 324
  • Cancer Research 176
  • Neurology 161
  • Surgery 149
Replace Filip Machaj with:
Filip Machaj Poland
Shanyi Li United States
Negin Parsamanesh Iran
Dayong Cai China
Li‐Jiuan Shen Taiwan
A Ramachandran India
Saiedeh Razi Soofiyani Iran
Shenghao Tu China
Manal S. Fawzy Egypt
Khalid Al‐Rasadi Oman
Jakub Rosik relative to Filip Machaj Poland Filip Machaj's profile →
Citations per field
00.5×1.5×
Filip Machaj · 1×
Citations per year

Countries citing papers authored by Jakub Rosik

Since Specialization
Citations

This map shows the geographic impact of Jakub Rosik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Rosik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Rosik more than expected).

Fields of papers citing papers by Jakub Rosik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Rosik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Rosik. The network helps show where Jakub Rosik may publish in the future.

Co-authorship network of co-authors of Jakub Rosik

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Rosik. A scholar is included among the top collaborators of Jakub Rosik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Rosik. Jakub Rosik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 0
4 1
5 7
6 11
7 96
8
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatmentbreakdown →
180
9 70
10 4
11
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
2
12 114
13 23
14 126
15 13
16
New therapies for the treatment of heart failure: a summary of recent accomplishments
5
17 28
18 84
19 198
20 1

About Jakub Rosik

Jakub Rosik is a scholar working on Infectious Diseases, Genetics and Behavioral Neuroscience, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). The work is most often cited by research in Infectious Diseases (324 citations), Cancer Research (176 citations) and Neurology (161 citations). Jakub Rosik has collaborated with scholars based in Poland, Canada and United States. Frequent co-authors include Filip Machaj, Bartosz Szostak, Saeid Ghavami, Katarzyna Kotfis, Sylwester Drożdżal, Kacper Lechowicz, Marek Łoś, Andrzej Pawlik, Tayyebeh Madrakian and Shayan Amiri. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Biotechnology Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026